Myriad RBM Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Myriad RBM Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011367
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Myriad RBM Inc (Myriad RBM), formerly Rules Based Medicine Inc, a subsidiary of Myriad Genetics Inc, is an immunoassay testing laboratory that provides protein biomarker products and services. The company’s products and services include HumanMAP services that assist investigators in the discovery, validation, and clinical use of biomarker patterns in biological samples. It also offers ultrasensitive immunoassays, custommap builder, blood collection and culture tube, aggrecan core protein, and others. Myriad RBM’s multi-analyte profiling technology platform provides preclinical and clinical researchers with reproducible and quantitative data. The laboratory offers companion diagnostic, custom assay development, co-sponsored research programs, and innovative cell culture products and services. Myriad RBM is headquartered in Austin, Texas, the US.

Myriad RBM Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Myriad RBM Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Myriad RBM Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Myriad RBM Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Myriad RBM Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Myriad RBM Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Myriad RBM Inc, Medical Equipment, Deal Details 10
Asset Purchase 10
Rules-Based Medicine Acquires Intellectual Property Assets From Satoris 10
Partnerships 11
DaVita Enters Into Agreement With Myriad Genetics For Protein Biomarker Discovery 11
Bio-Rad Labs Enters Into Distribution Agreement With Myriad RBM For Multiplex Biomarker Kits 12
Acquisition 13
Myriad Genetics Acquires Rules-Based Medicine 13
Myriad RBM Inc – Key Competitors 15
Myriad RBM Inc – Key Employees 16
Myriad RBM Inc – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Myriad RBM Inc, Medical Equipment, Key Facts 2
Myriad RBM Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Myriad RBM Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Myriad RBM Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Myriad RBM Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Myriad RBM Inc, Deals By Market, 2011 to YTD 2017 8
Myriad RBM Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Rules-Based Medicine Acquires Intellectual Property Assets From Satoris 10
DaVita Enters Into Agreement With Myriad Genetics For Protein Biomarker Discovery 11
Bio-Rad Labs Enters Into Distribution Agreement With Myriad RBM For Multiplex Biomarker Kits 12
Myriad Genetics Acquires Rules-Based Medicine 13
Myriad RBM Inc, Key Competitors 15
Myriad RBM Inc, Key Employees 16

★海外企業調査レポート[Myriad RBM Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Monopar Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Monopar Therapeutics Inc (Monopar) is a biopharmaceutical company that develops drugs and drug combinations to improve clinical outcomes for cancer patients. The company’s pipeline product includes huATN-658, a humanized monoclonal antibody for the potential treatment of various cancers incl …
  • Simon Property Group Inc (SPG):企業の財務・戦略的SWOT分析
    Simon Property Group Inc (SPG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Panoptes Pharma GesmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Panoptes Pharma GesmbH (Panoptes Pharma) is a biotech company that develops small molecule based therapies to treat severe eye diseases. The company also develops products in the therapeutic areas of uveitis, viral conjunctivitis, and further indications. It concentrates on a new treatment f …
  • China Galaxy Securities Co., Ltd. (6881):企業の財務・戦略的SWOT分析
    China Galaxy Securities Co., Ltd. (6881) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Saladax Biomedical Inc:企業の製品パイプライン分析2018
    Summary Saladax Biomedical Inc (Saladax) is a medical equipment company that develops diagnostic tests. The company provides products such as My5-FU, MyPaclitaxel, MyImatinib and MyDocetaxel, among others. Its My5-FU measures and helps physicians to optimize a patient’s exposure to 5-fluorouracil, M …
  • YKK Corporation:企業の戦略・SWOT・財務情報
    YKK Corporation - Strategy, SWOT and Corporate Finance Report Summary YKK Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • PlantForm Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary PlantForm Corp (PlantForm) is a biopharmaceutical company that develops and produces specialty antibody and protein drugs. The company’s pipeline products include biosimilar ranibizumab, trastuzumab, hD9 antibody for ricin exposure, recombinant butyrylcholinesterase, antibodies for HIV or AI …
  • Herstal SA:企業の戦略・SWOT・財務情報
    Herstal SA - Strategy, SWOT and Corporate Finance Report Summary Herstal SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Neenah Inc:企業の戦略・SWOT・財務情報
    Neenah Inc - Strategy, SWOT and Corporate Finance Report Summary Neenah Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Atlas Copco AB (ATCO A)-石油・ガス分野:企業M&A・提携分析
    Summary Atlas Copco AB (Atlas Copco) is an industrial productivity solutions provider. It develops and manufactures vacuum solutions, air treatment systems, compressors, assembly systems, construction and mining equipment, and power tools. Its product portfolio includes air and gas compressors, mach …
  • TETRA Technologies Inc (TTI):石油・ガス:M&Aディール及び事業提携情報
    Summary TETRA Technologies Inc (TETRA) is an oil and gas company that offers completion fluids and associated products and services. The company’s services comprise compression services, fluid, filtration and tools services, offshore services, production testing, rig cooling services, technology cen …
  • Thermax Ltd (THERMAX):企業の財務・戦略的SWOT分析
    Thermax Ltd (THERMAX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Canadian Natural Resources, Ltd.:企業の戦略・SWOT・財務情報
    Canadian Natural Resources, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Canadian Natural Resources, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Exide Technologies:企業の戦略的SWOT分析
    Exide Technologies - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Biosceptre International Ltd:企業の製品パイプライン分析2018
    Summary Biosceptre International Ltd (Biosceptre) is a biotechnology company that develops antibody technologies for applications in the diagnosis and treatment of cancer. The company develops imaging technologies to detect and monitor cancer. Its diagnostic products are used for the detection of va …
  • MILEI GmbH:企業の戦略・SWOT・財務情報
    MILEI GmbH - Strategy, SWOT and Corporate Finance Report Summary MILEI GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Cheung Kong Infrastructure Holdings Ltd:戦略・SWOT・企業財務分析
    Cheung Kong Infrastructure Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Cheung Kong Infrastructure Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • U.S. Smokeless Tobacco Company:企業の戦略・SWOT・財務情報
    U.S. Smokeless Tobacco Company - Strategy, SWOT and Corporate Finance Report Summary U.S. Smokeless Tobacco Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Swiss International Air Lines Ltd.:企業の戦略・SWOT・財務情報
    Swiss International Air Lines Ltd. - Strategy, SWOT and Corporate Finance Report Summary Swiss International Air Lines Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Cairn Energy Plc (CNE):企業の財務・戦略的SWOT分析
    Cairn Energy Plc (CNE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆